Ajanta Pharmaceuticals Q2 Results

  • BSE: 532331
  • NSE: AJANTPHARM
  • ISIN: INE031B01049
  • Sector: Biotechnology & Drugs
BSE
2,391.8512.10 (0.51%)
Volume283.00
Updated: Sat 18 May, 2024 | 12:29:12
NSE
2,389.98.85 (0.37%)
Volume7.66 K
Updated: Sat 18 May, 2024 | 12:14:46
Today: 2,390.00
2,408.70
52-Wk: 1,229.77
2,531.95

Q2 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Ajanta Pharmaceuticals Q2 Results

    *All figures in crores except per share values
    Fiscal PeriodSep 23Jun 23QoQ Comp
    Total Revenue 1,028.441,021.040.72%
    Selling/ General/ Admin Expenses Total 222.27213.214.25%
    Depreciation/ Amortization 33.7133.181.60%
    Other Operating Expenses Total 259.39274.62-5.55%
    Total Operating Expense 771.49772.91-0.18%
    Operating Income 256.95248.133.55%
    Net Income Before Taxes 275.94269.042.56%
    Net Income 195.30208.12-6.16%
    Diluted Normalized EPS 15.5016.53-6.23%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumFor youGet App